Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay

The Journal of Molecular Diagnostics - Tập 5 Số 2 - Trang 96-102 - 2003
Kathleen M. Murphy1, Mark J. Levis2, Michael J. Hafez1, Tanya Geiger1, Lisa Cooper1, B. Douglas Smith2, Donald Small2, Karin Berg1
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Blume-Jensen, 2001, Oncogenic kinase signalling, Nature, 411, 355, 10.1038/35077225

Turner, 1996, FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells, Blood, 88, 3383, 10.1182/blood.V88.9.3383.bloodjournal8893383

McKenna, 2000, Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells, Blood, 95, 3489, 10.1182/blood.V95.11.3489

Birg, 1992, Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages, Blood, 80, 2584, 10.1182/blood.V80.10.2584.2584

Carow, 1996, Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias, Blood, 87, 1089, 10.1182/blood.V87.3.1089.bloodjournal8731089

Nakao, 1996, Internal tandem duplication of the flt3 gene found in acute myeloid leukemia, Leukemia, 10, 1911

Yamamoto, 2001, Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, Blood, 97, 2434, 10.1182/blood.V97.8.2434

Thiede, 2002, Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis, Blood, 99, 4326, 10.1182/blood.V99.12.4326

Kottaridis, 2001, The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials, Blood, 98, 1752, 10.1182/blood.V98.6.1752

Kiyoi, 1998, Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product, Leukemia, 12, 1333, 10.1038/sj.leu.2401130

Yokota, 1997, Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies: a study on a large series of patients and cell lines, Leukemia, 11, 1605, 10.1038/sj.leu.2400812

Abu-Duhier, 2001, Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia, Br J Haematol, 113, 983, 10.1046/j.1365-2141.2001.02850.x

Stirewalt, 2001, Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific, Leuk Res, 25, 1085, 10.1016/S0145-2126(01)00087-X

Levis, 2002, A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo, Blood, 99, 3885, 10.1182/blood.V99.11.3885

Levis, 2001, A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations, Blood, 98, 885, 10.1182/blood.V98.3.885

Kelly, 2002, CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML), Cancer Cell, 1, 421, 10.1016/S1535-6108(02)00070-3

Weisberg, 2002, Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412, Cancer Cell, 1, 433, 10.1016/S1535-6108(02)00069-7

Druker, 2001, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, N Engl J Med, 344, 1031, 10.1056/NEJM200104053441401

Kiyoi, 1997, Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho), Leukemia, 11, 1447, 10.1038/sj.leu.2400756

Nakano, 1999, Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene, Br J Haematol, 104, 659, 10.1046/j.1365-2141.1999.01256.x

Kottaridis, 2002, Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors, Blood, 100, 2393, 10.1182/blood-2002-02-0420

Shih, 2002, Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse, Blood, 100, 2387, 10.1182/blood-2002-01-0195

Whitman, 2001, Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study, Cancer Res, 61, 7233